UPS buys Italian pharmaceutical logistics company

user-gravatar Headshot

UPS on Thursday, Dec. 1, announced an agreement to purchase Italy-based Pieffe Group to support its ongoing global healthcare strategy, which has seen the company make investments to better serve its customer base in the pharmaceutical, biotech and medical device industries. The announcement follows the opening of five new dedicated facilities this year in North and South America, Europe and Asia.

Pieffe, a pharmaceutical logistics company, is a family-owned business with more than 35 years’ experience offering storage, distribution and cold chain solutions to pharmaceutical companies. Terms of the deal were not disclosed.

“Pieffe is a perfect fit for UPS,” says Jim Barber, president of UPS Europe. “The company shares UPS’s focus on high-quality service and compliance, as well as our deep-rooted culture of precision and innovation. Pieffe will make a valuable addition to UPS’s European healthcare network, and we look forward to welcoming their team to the UPS family.”

The acquisition also brings two healthcare distribution facilities to UPS’s existing global network, one in Milan and the other in Rome. They offer a combined space of nearly 753,500 square feet, including 12 cold storage areas, with options for further expansion. This adds to UPS’s global healthcare distribution footprint of more than 4 million square feet.

“This is a tremendous development for our company, our employees and our customers,” says Federico Peruzzi of Pieffe. “UPS’s renowned quality standards combined with its specialized global healthcare network will enable us to sustain the growth and momentum we’ve built up over more than 35 years, while ensuring our customers continue to experience excellent levels of service.”